Discrepancy between Clinical and Pathologic Stage: Impact on Prognosis after Radical Cystectomy

European Urology

Volumn 51, Issue 1, 2007, Pages 137-151

  Shariat, Shahrokh F ^a   Palapattu, Ganesh S ^b   Karakiewicz, Pierre I ^c   Rogers, Craig G ^b   Vazina, Amnon ^d   Bastian, Patrick J ^b   Schoenberg, Mark P ^b   Lerner, Seth P ^d   Sagalowsky, Arthur I ^a   Lotan, Yair ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Bladder cancer; Cystectomy; Recurrence; Stage; Survival

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; CYSTECTOMY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PELVIS LYMPHADENECTOMY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; RETROSPECTIVE STUDY; STANDARD; STATISTICAL SIGNIFICANCE; TRANSITIONAL CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; SURVIVAL RATE; URINARY BLADDER NEOPLASMS;

EID: 33751418969     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2006.05.021     Document Type: Article

References (23)

1. Stein J.P. Indications for early cystectomy. Urology 62 (2003) 591-595
2. Bianco Jr. F.J., Justa D., Grignon D.J., Sakr W.A., Pontes J.E., and Wood Jr. D.P. Management of clinical T1 bladder transitional cell carcinoma by radical cystectomy. Urol Oncol 22 (2004) 290-294
3. Pagano F., Bassi P., Galetti T.P., et al. Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumour, nodes and metastases classification. J Urol 145 (1991) 45-50
4. Dutta S.C., Smith Jr. J.A., Shappell S.B., Coffey C.S., Chang S.S., and Cookson M.S. Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy. J Urol 166 (2001) 490-493
5. Cheng L., Neumann R.M., Weaver A.L., et al. Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens. Am J Clin Pathol 113 (2000) 275-279
6. Ghoneim M.A., and Abol-Enein H. Lymphadenectomy with cystectomy: is it necessary and what is its extent?. Eur Urol 46 (2004) 457-461
7. Liedberg F., and Mansson W. Lymph node metastasis in bladder cancer. Eur Urol 49 (2006) 13-21
8. Marshall V.F. The relation of the preoperative estimate to the pathologic demonstration of the extent of vesical neoplasms. J Urol 68 (1952) 714-723
9. Herr H.W. The value of a second transurethral resection in evaluating patients with bladder tumours. J Urol 162 (1999) 74-76
10. Brauers A., Buettner R., and Jakse G. Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early?. J Urol 165 (2001) 808-810
11. Chang S.S., Hassan J.M., Cookson M.S., Wells N., and Smith Jr. J.A. Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathological stage. J Urol 170 (2003) 1085-1087
12. Sanchez-Ortiz R.F., Huang W.C., Mick R., Van Arsdalen K.N., Wein A.J., and Malkowicz S.B. An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma. J Urol 169 (2003) 110-115 discussion 115
13. Ooms E.C., Anderson W.A., Alons C.L., Boon M.E., and Veldhuizen R.W. Analysis of the performance of pathologists in the grading of bladder tumours. Hum Pathol 14 (1983) 140-143
14. Sharkey F.E., and Sarosdy M.F. The significance of central pathology review in clinical studies of transitional cell carcinoma in situ. J Urol 157 (1997) 68-70 discussion 70-1
15. Coblentz T.R., Mills S.E., and Theodorescu D. Impact of second opinion pathology in the definitive management of patients with bladder carcinoma. Cancer 91 (2001) 1284-1290
16. Herr H.W. Routine CT scan in cystectomy patients: does it change management?. Urology 47 (1996) 324-325
17. Paik M.L., Scolieri M.J., Brown S.L., Spirnak J.P., and Resnick M.I. Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy. J Urol 163 (2000) 1693-1696
18. Cookson M.S., Herr H.W., Zhang Z.F., Soloway S., Sogani P.C., and Fair W.R. The treated natural history of high risk superficial bladder cancer: 15-year outcome. J Urol 158 (1997) 62-67
19. Malkowicz S.B., Nichols P., Lieskovsky G., Boyd S.D., Huffman J., and Skinner D.G. The role of radical cystectomy in the management of high grade superficial bladder cancer (PA, P1, PIS and P2) [see comments]. J Urol 144 (1990) 641-645
20. Malavaud B. T1G3 bladder tumours: the case for radical cystectomy. Eur Urol 45 (2004) 406-410
21. Freeman J.A., Esrig D., Stein J.P., et al. Radical cystectomy for high risk patients with superficial bladder cancer in the era of orthotopic urinary reconstruction. Cancer 76 (1995) 833-839
22. Hollenbeck B.K., Miller D.C., Dunn R.L., Montie J.E., and Wei J.T. The effects of stage divergence on survival after radical cystectomy for urothelial cancer. Urol Oncol 23 (2005) 77-81
23. Herr H.W., Faulkner J.R., Grossman H.B., et al. Surgical factors influence bladder cancer outcomes: a cooperative group report. J Clin Oncol 22 (2004) 2781-2789